ArticleDiabetologia2019

CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter].

Gisela M Vaitaitis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.